The incidence and severity of anemia observed in our study was higher than that observed with first – line fludarabine monotherapy; this could be secondary to extensive prior therapy in our patient population, but could also be secondary to red blood cell membrane damage by methoxyamine, causing low-grade hemolysis and providing an explanation for decreases in haptoglobin observed in 6 subjects. Here, HP is linked to anemia (phenotype).